Steady-state pharmacokinetics and glucodynamics of the novel, long-acting basal insulin LY2605541 dosed once-daily in patients with type 2 diabetes mellitus-Reference-Cited by-同舟云学术

Steady-state pharmacokinetics and glucodynamics of the novel, long-acting basal insulin LY2605541 dosed once-daily in patients with type 2 diabetes mellitus

Published:2013-10-31 Issue:4 Volume:16 Page:344-350
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Sinha V. P.¹,Howey D. C.¹,Choi S. L.¹,Mace K. F.¹,Heise T.²

Affiliation:

1. Eli Lilly and Company; Indianapolis IN USA

2. Profil; Neuss Germany

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12222/fullpdf

Reference20 articles.

1. The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients;Riddle;Diabetes Care,2003

2. DURAbility of basal versus lispro mix 75/25 insulin efficacy (DURABLE) trial 24-week results: safety and efficacy of insulin lispro mix 75/25 versus insulin glargine added to oral antihyperglycemic drugs in patients with type 2 diabetes;Buse;Diabetes Care,2009

3. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes;Nathan;Diabetes Care,2009

4. Insulin therapy for type 2 diabetes;Swinnen;Diabetes Care,2009

5. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro;Lepore;Diabetes,2000

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insulin Analogs and the Mode of Insulin Delivery: Recent Advances and Challenges;Current Pharmaceutical Biotechnology;2024-04-02

2. Pharmacokinetic and pharmacodynamic properties of the novel basal insulin Fc (insulin efsitora alfa), an insulin fusion protein in development for once‐weekly dosing for the treatment of patients with diabetes;Diabetes, Obesity and Metabolism;2023-01-09

3. Preclinical Characterization of LY3209590, a Novel Weekly Basal Insulin Fc-Fusion Protein;Journal of Pharmacology and Experimental Therapeutics;2022-07-15

4. New Horizons: Next-Generation Insulin Analogues: Structural Principles and Clinical Goals;The Journal of Clinical Endocrinology & Metabolism;2021-11-24

5. Structural principles of insulin formulation and analog design: A century of innovation;Molecular Metabolism;2021-10